Completed PHASE4 INTERVENTIONAL 2-arm NCT02646904

Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis

Sponsor: Stefania La Grutta, MD

Interventions CERCHIO 10 mg/ml OS Nasal Beclomethasone Dipropionate

Updated 7 times since 2017 Last updated: Nov 17, 2017 Started: May 31, 2016 Primary completion: Jun 30, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Allergic Rhinitis, this trial is completed. The trial is conducted by Stefania La Grutta, MD and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Jul 2019 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Nov 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jan 2017 — Nov 2017 [monthly]

Recruiting PHASE4

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stefania La Grutta, MD

Data source: Istituto per la Ricerca e l'Innovazione Biomedica

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palermo, Italy